Viracta Therapeutics (VIRX)
(Delayed Data from NSDQ)
$0.22 USD
0.00 (-0.27%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $0.22 0.00 (-1.70%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.21 |
EPS Last Quarter | -0.25 |
Last EPS Surprise | 28.57% |
ABR | 2.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.69 |
Next Year | -0.35 |
EPS (TTM) | -1.16 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.21 | -0.09 | -0.69 | -0.35 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.21 | -0.09 | -0.69 | -0.35 |
High Estimate | -0.21 | -0.09 | -0.69 | -0.35 |
Low Estimate | -0.21 | -0.09 | -0.69 | -0.35 |
Year ago EPS | -0.33 | -0.35 | -1.32 | -0.69 |
Year over Year Growth Est. | 36.36% | 74.29% | 47.73% | 49.28% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.21 | -0.09 | -0.69 | -0.35 |
7 Days Ago | -0.21 | -0.09 | -0.69 | -0.35 |
30 Days Ago | -0.29 | -0.23 | -1.06 | -0.35 |
60 Days Ago | -0.30 | -0.32 | -1.24 | -1.05 |
90 Days Ago | -0.30 | -0.32 | -1.24 | -1.05 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.21 | -0.09 | -0.69 | -0.35 |
Zacks Consensus Estimate | -0.21 | -0.09 | -0.69 | -0.35 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.25 | -0.23 | -0.35 | -0.33 | NA |
Estimate | -0.35 | -0.35 | -0.30 | -0.33 | NA |
Difference | 0.10 | 0.12 | -0.05 | 0.00 | 0.04 |
Surprise | 28.57% | 34.29% | -16.67% | 0.00% | 11.55% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more